Efficacy of Lady Convert to Dasatinib in Chronic Myeloid Leukemia Patients Who Inresponse or Intolerance to Imatinib

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
• 作者

  Liu Liang; Na Xu; Xuan Zhou; Huang JiXian; Chen Chen; Lin Tong; Wu Wan-Er; Yin Changxin; Liu Qifa; Liu Xiaoli;

  展开▼
• 作者单位

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  NanFangHospital Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  Southern Med Univ Nanfang Hosp Guangzhou Guangdong Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词

  Chronic myeloid leukemia; Imatinib; Dasatinib; Early conversion;

  机译：慢性骨髓白血病;伊替尼;达斯托涅替尼;早期转换;